These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34494955)

  • 41. Infliximab equivalently suppresses oxidative stress compared to tocilizumab among well-controlled patients with rheumatoid arthritis.
    Kizaki K; Yamashita F; Hayashi T; Funakoshi N
    Int J Rheum Dis; 2018 Oct; 21(10):1815-1821. PubMed ID: 27778459
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Semi-quantitative analysis of
    Ravikanth R; Singh JK
    World J Nucl Med; 2020; 19(4):347-352. PubMed ID: 33623503
    [No Abstract]   [Full Text] [Related]  

  • 43. Treating neutrophilic inflammation in COPD by targeting ALX/FPR2 resolution pathways.
    Bozinovski S; Anthony D; Anderson GP; Irving LB; Levy BD; Vlahos R
    Pharmacol Ther; 2013 Dec; 140(3):280-9. PubMed ID: 23880288
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis: acute phase reactant levels contribute separately to predicting outcome at one year.
    Kay J; Morgacheva O; Messing SP; Kremer JM; Greenberg JD; Reed GW; Gravallese EM; Furst DE
    Arthritis Res Ther; 2014 Feb; 16(1):R40. PubMed ID: 24485007
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A multi-biomarker disease activity score can predict sustained remission in rheumatoid arthritis.
    Ma MHY; Defranoux N; Li W; Sasso EH; Ibrahim F; Scott DL; Cope AP
    Arthritis Res Ther; 2020 Jun; 22(1):158. PubMed ID: 32580789
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasma metabolomic profiling in patients with rheumatoid arthritis identifies biochemical features predictive of quantitative disease activity.
    Hur B; Gupta VK; Huang H; Wright KA; Warrington KJ; Taneja V; Davis JM; Sung J
    Arthritis Res Ther; 2021 Jun; 23(1):164. PubMed ID: 34103083
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of disease activity in rheumatoid arthritis by Routine Assessment of Patient Index Data 3 (RAPID3) and its correlation to Disease Activity Score 28 (DAS28) and Clinical Disease Activity Index (CDAI): an Indian experience.
    Singh H; Gupta V; Ray S; Kumar H; Talapatra P; Kaur M; Kumar S; Arya S; Mathur R; Ghangas N
    Clin Rheumatol; 2012 Dec; 31(12):1663-9. PubMed ID: 22983768
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lipoxin A4 activates ALX/FPR2 to attenuate inflammation in Aspergillus fumigatus keratitis.
    Zhu X; Peng X; Lin J; Zhang Y; He H; Zhao G
    Int Immunopharmacol; 2021 Jul; 96():107785. PubMed ID: 34162149
    [TBL] [Abstract][Full Text] [Related]  

  • 49. How much does Disease Activity Score in 28 joints ESR and CRP calculations underestimate disease activity compared with the Simplified Disease Activity Index?
    Fleischmann R; van der Heijde D; Koenig AS; Pedersen R; Szumski A; Marshall L; Bananis E
    Ann Rheum Dis; 2015 Jun; 74(6):1132-7. PubMed ID: 25143522
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of sustained intensive therapy with disease modifying anti-rheumatic drugs in rheumatoid arthritis: a 5-year real-world consecutive study.
    Cai YM; Li R; Ye H; He J; Sun XL; Jin JY; Liu JJ; Gan YZ; You XJ; Xu J; Shi LJ; Cheng G; Wang QW; Li ZG
    Chin Med J (Engl); 2020 Jun; 133(12):1397-1403. PubMed ID: 32496302
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biomarker-guided clinical development of the first-in-class anti-inflammatory FPR2/ALX agonist ACT-389949.
    Stalder AK; Lott D; Strasser DS; Cruz HG; Krause A; Groenen PM; Dingemanse J
    Br J Clin Pharmacol; 2017 Mar; 83(3):476-486. PubMed ID: 27730665
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Targeting formyl peptide receptor 2 reduces leukocyte-endothelial interactions in a murine model of stroke.
    Smith HK; Gil CD; Oliani SM; Gavins FN
    FASEB J; 2015 May; 29(5):2161-71. PubMed ID: 25690650
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of human immunodeficiency virus infection on disease activity in rheumatoid arthritis: a retrospective study in South Africans.
    Tarr G; Makda M; Musenge E; Tikly M
    J Rheumatol; 2014 Aug; 41(8):1645-9. PubMed ID: 25028384
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Circulating Level of Blood Iron and Copper Associated with Inflammation and Disease Activity of Rheumatoid Arthritis.
    Wang H; Zhang R; Shen J; Jin Y; Chang C; Hong M; Guo S; He D
    Biol Trace Elem Res; 2023 Jan; 201(1):90-97. PubMed ID: 35344152
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of Disease Activity Score (DAS)28- erythrocyte sedimentation rate and DAS28- C-reactive protein threshold values.
    Inoue E; Yamanaka H; Hara M; Tomatsu T; Kamatani N
    Ann Rheum Dis; 2007 Mar; 66(3):407-9. PubMed ID: 16926186
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Correlation of rheumatoid arthritis activity indexes (Disease Activity Score 28 measured with ESR and CRP, Simplified Disease Activity Index and Clinical Disease Activity Index) and agreement of disease activity states with various cut-off points in a Northeastern Brazilian population.
    Medeiros MM; de Oliveira BM; de Cerqueira JV; Quixadá RT; de Oliveira ÍM
    Rev Bras Reumatol; 2015; 55(6):477-84. PubMed ID: 25772662
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differences in disease activity measures in patients with rheumatoid arthritis who achieved DAS, SDAI, or CDAI remission but not Boolean remission.
    Aletaha D; Wang X; Zhong S; Florentinus S; Monastiriakos K; Smolen JS
    Semin Arthritis Rheum; 2020 Apr; 50(2):276-284. PubMed ID: 31590930
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interchangeability of 28-joint disease activity scores using the erythrocyte sedimentation rate or the C-reactive protein as inflammatory marker.
    Siemons L; Vonkeman HE; ten Klooster PM; van Riel PL; van de Laar MA
    Clin Rheumatol; 2014 Jun; 33(6):783-9. PubMed ID: 24562719
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The relationship between disease activity with pan-immune-inflammatory value and systemic immune-inflammation index in rheumatoid arthritis.
    Başaran PÖ; Dogan M
    Medicine (Baltimore); 2024 Mar; 103(9):e37230. PubMed ID: 38428850
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of the FPR2/ALX receptor in atherosclerosis development and plaque stability.
    Petri MH; Laguna-Fernández A; Gonzalez-Diez M; Paulsson-Berne G; Hansson GK; Bäck M
    Cardiovasc Res; 2015 Jan; 105(1):65-74. PubMed ID: 25341894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.